ACUT (Accustem Sciences) Accounts Payable: $0.62 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ACUT Accustem Sciences Inc ACUT
29 GF Score
Price $0.16
View Full Analysis

What is Accustem Sciences Accounts Payable?

Accustem Sciences ACUT -28.89% 29 Accounts Payable is $0.62 Mil as of Jun. 2026. GuruFocus rates ACUT with a GF Score™ of 29/100.

Accustem Sciences's Accounts Payable for the quarter that ended in Jun. 2026 was $0.62 Mil.

Accustem Sciences's quarterly Accounts Payable increased from Dec. 2025 ($0.70 Mil) to Mar. 2026 ($0.74 Mil) but then declined from Mar. 2026 ($0.74 Mil) to Jun. 2026 ($0.62 Mil).

Accustem Sciences's annual Accounts Payable increased from Dec. 2023 ($0.58 Mil) to Dec. 2024 ($0.81 Mil) but then declined from Dec. 2024 ($0.81 Mil) to Dec. 2025 ($0.70 Mil).

Accustem Sciences Accounts Payable Related Terms

Accustem Sciences Accounts Payable Historical Data

* Premium members only.

The historical data trend for Accustem Sciences's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accustem Sciences Accounts Payable Chart

Accustem Sciences Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Accounts Payable
0.31 0.58 0.81 0.70

Accustem Sciences Quarterly Data
Jun21 Sep21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.86 0.92 0.70 0.74 0.62
ACUT
29GF Score
Accustem Sciences Inc ACUT
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Accustem Sciences Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $0.62 Mil mean?
Accustem Sciences (ACUT) has a Accounts Payable of $0.62 Mil as of Jun. 2026. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Accustem Sciences and its competitors.
Is Accustem Sciences' Accounts Payable too high?
Accustem Sciences' current Accounts Payable is $0.62 Mil. Overall, Accustem Sciences has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Accustem Sciences' Accounts Payable compare to SPRC and ONCO?
Accustem Sciences' Accounts Payable of $0.62 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Accustem Sciences and its competitors. Accustem Sciences's current Accounts Payable is $0.62 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accustem Sciences stock overvalued right now?
Accustem Sciences (ACUT) has a current Accounts Payable of $0.62 Mil. The current Accounts Payable is $0.62 Mil. Accustem Sciences' overall GF Score™ is 29/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Accustem Sciences (ACUT), the current Accounts Payable is $0.62 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Accustem Sciences Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10001
Accustem Sciences Inc is a clinical stage diagnostics company dedicated to improving quality of life and outcomes for the millions of people who are diagnosed with cancer each year. The company's product, StemPrintER, is a genomic platform for predicting distant recurrence risk in luminal, ER+/HER2-negative breast cancer patients. Additionally, It offers ancillary commodity testing to provide further insights. Validated in various retrospective cohorts, StemPrintER shows promise for oncology clinics. Revenue is generated through product commercialization and testing services.
29GF Score

Get the complete analysis for ACUT

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.16
Price